Pages that link to "Q37512075"

The following pages link to Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma (Q37512075):

Displaying 28 items.

• Epstein-Barr virus latent genes (Q28082701) ‎ (← links)
• Animal models of tumorigenic herpesviruses--an update (Q28083747) ‎ (← links)
• EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management (Q35040644) ‎ (← links)
• Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma (Q35808018) ‎ (← links)
• Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation (Q36199894) ‎ (← links)
• Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression. (Q36246412) ‎ (← links)
• Frequency of Epstein Barr Virus Type 1 Among Nasopharyngeal Carcinomas in Iranian Patients (Q36323473) ‎ (← links)
• Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies (Q38188591) ‎ (← links)
• Latent Membrane Protein 2 (LMP2). (Q38597241) ‎ (← links)
• Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis (Q38953504) ‎ (← links)
• Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease (Q40269570) ‎ (← links)
• Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential. (Q40375799) ‎ (← links)
• Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression (Q41055307) ‎ (← links)
• Not like a wrecking ball: EBV fine-tunes MYC lymphomagenesis. (Q41815216) ‎ (← links)
• The IgH 3' regulatory region influences lymphomagenesis in Igλ-Myc mice (Q41826032) ‎ (← links)
• EBV germinates lymphoma from the germinal center in a battle with T and NK cells (Q43083592) ‎ (← links)
• EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice (Q47598522) ‎ (← links)
• EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts. (Q51735191) ‎ (← links)
• Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas. (Q55272984) ‎ (← links)
• Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis (Q58567030) ‎ (← links)
• Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma (Q58721423) ‎ (← links)
• Two Pathways of p27 Degradation Are Required for Murine Lymphoma Driven by Myc and EBV Latent Membrane Protein 2A (Q64109721) ‎ (← links)
• EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis. (Q64971530) ‎ (← links)
• Post-transplant lymphoproliferative disorders (Q89217688) ‎ (← links)
• Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development (Q90383656) ‎ (← links)
• The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies (Q91996237) ‎ (← links)
• Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus (Q93010927) ‎ (← links)
• Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers (Q94593890) ‎ (← links)